Instruction for use: Vero-Anaprilin

Trade name of the drug – Vero-Anaprilin

Dosage Form: tablets

Active substance:Propranololum

ATX

C07AA05 Propranolol

Pharmacotherapeutic group: Beta-blockers

The nosological classification (ICD-10)

E05 Thyrotoxicosis [hyperthyroidism]: Von Basedow's disease; Basedow's disease; hyperthyroidism; Goitre diffuse toxic; Increased thyroid function; tireotoksicski reaction; Toxic diffuse goiter; Toxic goiter; Enlargement of the thyroid gland with symptoms of hyperthyroidism; The phenomenon of iodine Basedow

G43 Migraine: The pain of migraine; Migraine; hemiplegic migraine; Migraine headache; A migraine attack; Continuous headache; hemicranias

G90 Disorders of autonomic [autonomous] nervous system: angiodystonia; vasovegetative manifestations; vasomotor dystonia; vegetative dystonia; autonomic dysfunction; vegetative lability; Vegetative-vascular disorders; autonomic dysfunction; vasoneurosis; Vegetative-vascular dystonia; vegetative-vascular disorders; Vegetative-vascular disorders; Dystonia vegetovascular; Dystonia neurocirculatory; neuro disorder; Cardiopsychoneurosis; Neurocirculatory dystonia of hypertensive type; Primary neurovegetative syndrome; The syndrome of vegetative dystonia

I10 Essential (primary) hypertension: hypertension; Arterial hypertension; Arterial hypertension crisis course; Essential Hypertension; Essential hypertension; Essential hypertension; Essential hypertension; Essential hypertension; Primary hypertension; Arterial hypertension, complications of diabetes; The sudden increase in blood pressure; Hypertensive disorders of blood circulation; hypertensive condition; hypertensive crises; arterial Hypertension; malignant Hypertension; Hypertonic disease; hypertensive crises; accelerated hypertension; malignant hypertension; The aggravation of hypertensive disease; Transient hypertension; Isolated systolic hypertension

I15 Secondary hypertension: Arterial hypertension, complications of diabetes; hypertension; The sudden increase in blood pressure; Hypertensive disorders of blood circulation; hypertensive condition; hypertensive crises; hypertension; arterial Hypertension; malignant Hypertension; hypertensive crises; accelerated hypertension; malignant hypertension; The aggravation of hypertensive disease; Transient hypertension; hypertension; Arterial hypertension; Arterial hypertension crisis course; renovascular hypertension; Hypertension symptomatic; Renal hypertension; Renovascular hypertension; renovascular hypertension; Symptomatic hypertension

I20 Angina [angina]: Heberden disease; Angina pectoris; The attack of angina pectoris; recurrent angina; Spontaneous angina; Stable angina pectoris; Angina rest; Angina progressing; Angina mixed; Angina spontaneous; stable angina; Chronic stable angina; Angina Syndrome X

I20.0 Unstable angina: heberden disease; Angina pectoris; The attack of angina pectoris; recurrent angina; Spontaneous angina; Stable angina pectoris; Angina rest; Angina progressing; Angina mixed; Angina spontaneous; stable angina; Chronic stable angina; Angina Syndrome X

I25 Chronic ischemic heart disease: Coronary heart disease on the background of hypercholesterolemia; Coronary heart disease is a chronic; Coronary heart disease; Stable coronary artery disease; Percutaneous transluminal angioplasty; Myocardial ischemia, arteriosclerosis; Recurrent myocardial ischemia

I42.1 Obstructive hypertrophic cardiomyopathy: Asymmetrical hypertrophy of the interventricular septum; Hypertrophic obstructive cardiomyopathy; Obliteriruschaya restrictive cardiomyopathy; Hypertrophic cardiomyopathy; Hypertrophic obstructive cardiomyopathy; Myocardial hypertrophy with obstruction

I49.9 Irregular heartbeat, unspecified: Paroxysmal supraventricular tachycardia; extrasystole arrhythmia; Atrial fibrillation tachysystolic; supraventricular tachyarrhythmia; supraventricular arrhythmias; AV reciprocating tachycardia; AV-nodal reciprocating tachycardia; ventricular fibrillation; Irregular heartbeat; Antidromic reciprocating tachycardia; Cardiac arrhythmias; Arrhythmias; Arrhythmia; Heart arythmy; Arrhythmia due to hypokalemia; ventricular tachyarrhythmias; The high frequency of ventricular contraction; Cardiac arrhythmias; Paroxysmal supraventricular arrhythmia; Paroxysmal supraventricular arrhythmia; Paroxysmal dysrhythmia; Paroxysmal atrial-ventricular rhythm; cardiac arrhythmias; supraventricular tachycardia; tachyarrhythmia; Precordial abnormal pulsation

R25.1 Tremor, unspecified: shake; senile tremor; Tremor; muscle tremors; Tremor when portal-systemic encephalopathy; Essential tremor family; Titubatsiya

Composition (per tablet):

1 tablet contains 0.04 g of propranolol; in blisters of 10 pieces, in a box of 5 packages.; or in a dark glass jar 50 pcs., in box 1 of the bank.

Pharmacological Properties of Vero-Anaprilin

Pharmachologic effect - antianginal, hypotensive, anti-arrhythmic.

Beta-adrenoceptor blocking, has a membrane-stabilizing effect, reduces the automatism of the sinus node, the excitability of the myocardium, the occurrence of ectopic foci of excitation exerts membrane-stabilizing effect, slows heart rate slows AV conduction, reduces myocardial contractility, and its need for oxygen.

Indications of Vero-Anaprilin

Angina, progressive angina, silent myocardial ischemia, hypertension, arrhythmia, hypertrophic cardiomyopathy, cardiopsychoneurosis, thyrotoxicosis, migraine, essential tremor family.

Contraindications

Hypersensitivity, decompensated heart failure, asthma, bradycardia, hypotension, a violation of the peripheral circulation, Raynaud's disease, myocardial infarction, insulin, treatment with monoamine oxidase inhibitors.

Side effect

From the nervous system and sensory organs: weakness, dizziness.

Cardio-vascular system and blood (blood, hemostasis): bradycardia, AV block, heart failure, peripheral artery spasm,

Other: bronchospasm, indigestion, itchy skin.

Dosage and Administration

Inside, hypertension - 0.04 g 2 times a day, gradually increasing the dose to 0.12-0.16 g in 2 divided doses; migraine and angina - 0.02 g 4 times a day, then - 0.04 g reception; arrhythmia, cardiomyopathy, thyrotoxicosis - by 0.01-0.04 g 3-4 times a day. The maximum daily dose - 0.32 g

Precautionary measures

With caution is prescribed for acute myocardial infarction, abnormal liver and kidney function.

Storage conditions of Vero-Anaprilin

In a dry, dark place.

Keep out of the reach of children.

Shelf life

4 years.

Do not use beyond the expiration date printed on the package.